Published in Schizophr Bull on May 15, 2007
Emotional memory in schizophrenia. Schizophr Bull (2008) 1.11
Cognitive performance and functional competence as predictors of community independence in schizophrenia. Schizophr Bull (2008) 0.95
S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance. Cardiovasc Psychiatry Neurol (2010) 0.86
Glucose administration prior to a divided attention task improves tracking performance but not word recognition: evidence against differential memory enhancement? Psychopharmacology (Berl) (2008) 0.85
Effects of individual glucose levels on the neuronal correlates of emotions. Front Hum Neurosci (2013) 0.79
Expression of immune genes on chromosome 6p21.3-22.1 in schizophrenia. Brain Behav Immun (2013) 0.78
Glucose modulates event-related potential components of recollection and familiarity in healthy adolescents. Psychopharmacology (Berl) (2009) 0.76
No effect of glucose administration in a novel contextual fear generalization protocol in rats. Transl Psychiatry (2016) 0.75
Are neurocognitive, clinical and social dysfunctions in schizotaxia reversible pharmacologically?: Results from the Changsha study. Asian J Psychiatr (2012) 0.75
Insulin signalling and the regulation of glucose and lipid metabolism. Nature (2001) 16.41
What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry (1996) 11.03
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62
A review of MRI findings in schizophrenia. Schizophr Res (2001) 8.95
Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology (1998) 8.73
The medial temporal lobe memory system. Science (1991) 7.86
Identification of separable cognitive factors in schizophrenia. Schizophr Res (2004) 5.34
Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry (2004) 5.10
Competition among multiple memory systems: converging evidence from animal and human brain studies. Neuropsychologia (2003) 4.25
Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiatry (1991) 3.88
The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med (1994) 3.71
Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci (1998) 3.71
Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry (1999) 3.69
The primacy of cognition in schizophrenia. Am Psychol (2005) 3.64
Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry (1994) 3.59
Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry (2003) 3.54
The temporolimbic system theory of positive schizophrenic symptoms. Schizophr Bull (1997) 3.40
The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) (2004) 3.11
Neuron-glia metabolic coupling and plasticity. J Exp Biol (2006) 3.00
Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry (1998) 2.92
Multiple parallel memory systems in the brain of the rat. Neurobiol Learn Mem (2002) 2.90
Medicine. What are the right targets for psychopharmacology? Science (2003) 2.86
Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A (2005) 2.68
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry (2000) 2.66
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry (1998) 2.56
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry (2002) 2.52
Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci (1999) 2.50
Brain networks associated with cognitive reserve in healthy young and old adults. Cereb Cortex (2005) 2.37
Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci (2005) 2.37
A theory of cognitive control, aging cognition, and neuromodulation. Neurosci Biobehav Rev (2002) 2.37
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry (2005) 2.29
Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry (1992) 2.27
1999 Curt P. Richter award. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology (2000) 2.20
Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch Gen Psychiatry (2003) 2.15
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull (1999) 2.10
Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry (2001) 2.04
Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry (2002) 2.02
The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull (1999) 1.99
Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A (2003) 1.95
To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology (2000) 1.89
Cognitive deficits as treatment targets in schizophrenia. Schizophr Res (2004) 1.86
A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull (1984) 1.85
Cognitive reserve and the neurobiology of cognitive aging. Ageing Res Rev (2004) 1.79
Proposal for a noradrenaline hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.77
Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry (2000) 1.77
Cognitive performance is associated with glucose regulation in healthy elderly persons and can be enhanced with glucose and dietary carbohydrates. Am J Clin Nutr (2000) 1.75
Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev (2003) 1.71
Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia. Biol Psychiatry (2000) 1.71
Patterns of fetal and childhood growth and the development of psychosis in young males: a cohort study. Am J Epidemiol (2003) 1.67
Glucose improvement of memory: a review. Eur J Pharmacol (2004) 1.66
Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem (2003) 1.63
Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychopharmacology (2001) 1.61
Carbohydrate-induced memory impairment in adults with type 2 diabetes. Diabetes Care (2003) 1.61
Frontal lobe damage produces episodic memory impairment. J Int Neuropsychol Soc (1995) 1.59
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biol Psychiatry (2002) 1.59
Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biol Psychiatry (2001) 1.59
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry (1999) 1.57
Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. Arch Gen Psychiatry (1994) 1.55
Family history of type 2 diabetes in schizophrenic patients. Lancet (1989) 1.54
MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res (2003) 1.54
Glycogen: the forgotten cerebral energy store. J Neurosci Res (2003) 1.50
Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. Proc Natl Acad Sci U S A (2000) 1.48
Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Brain Res Rev (2003) 1.48
Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. J Abnorm Psychol (1995) 1.44
Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry (1999) 1.43
Working and long-term memory deficits in schizophrenia: is there a common prefrontal mechanism? J Abnorm Psychol (2002) 1.41
Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry (1999) 1.41
Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. Eur J Pharmacol (2004) 1.41
Inhibition of glycogenolysis in astrocytes interrupts memory consolidation in young chickens. Glia (2006) 1.40
The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes (2001) 1.40
Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers. Schizophr Res (2005) 1.40
How do memory systems interact? Evidence from human classification learning. Neurobiol Learn Mem (2004) 1.40
Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? Diabetes Metab Res Rev (2000) 1.40
A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol Psychiatry (2004) 1.39
Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care (1998) 1.39
Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives. Arch Gen Psychiatry (2002) 1.38
Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia (1995) 1.38
Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. Biol Psychiatry (2000) 1.35
Altered brain activation in dorsolateral prefrontal cortex in adolescents and young adults at genetic risk for schizophrenia: an fMRI study of working memory. Schizophr Res (2006) 1.35
Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr Clin North Am (2003) 1.34
A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr Bull (2003) 1.34
The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol (2000) 1.32
Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology (2006) 1.31
The nature of learning and memory impairments in schizophrenia. J Int Neuropsychol Soc (1995) 1.31
Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia. Biol Psychiatry (2003) 1.29
Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia. Biol Psychiatry (1994) 1.28
Predicting drug efficacy for cognitive deficits in schizophrenia. Schizophr Bull (2005) 1.28
Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. Proc Natl Acad Sci U S A (1996) 1.26
Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr Res (2006) 1.25
Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci (2002) 1.25
Neuroimaging of declarative memory in schizophrenia. Scand J Psychol (2001) 1.23
Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology (2004) 1.23
Multiple frontal systems controlling response speed. Neuropsychologia (2005) 1.22
Improving influence of insulin on cognitive functions in humans. Neuroendocrinology (2001) 1.22
The neuropsychological signature of schizophrenia: generalized or differential deficit? Am J Psychiatry (1994) 1.21
Forms of memory failure in schizophrenia. J Abnorm Psychol (1992) 1.20
Role of glucose in regulating the brain and cognition. Am J Clin Nutr (1995) 1.19
Neurobehavioral deficits in offspring of schizophrenic parents: liability indicators and predictors of illness. Am J Med Genet (2000) 1.19
Coordination of multiple memory systems. Neurobiol Learn Mem (2004) 1.18
Cognitive demand and blood glucose. Physiol Behav (2001) 1.18
Automatically parcellating the human cerebral cortex. Cereb Cortex (2004) 18.32
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00
Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A (2009) 6.09
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry (2011) 3.66
Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am J Psychiatry (2008) 3.29
North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull (2007) 3.28
Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology (2009) 3.27
Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry (2008) 3.27
Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry (2006) 3.17
Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiatry (2005) 3.08
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90
The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull (2006) 2.53
Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex (2006) 2.44
Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol (2004) 2.30
Hierarchical genetic organization of human cortical surface area. Science (2012) 2.28
Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci (2005) 2.25
Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry (2005) 2.18
Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull (2003) 2.04
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99
Genetic and environmental influences on the size of specific brain regions in midlife: the VETSA MRI study. Neuroimage (2009) 1.94
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry (2013) 1.87
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry (2011) 1.86
Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality. Brain Dev (2005) 1.81
North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res (2012) 1.79
MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder. Am J Psychiatry (2002) 1.72
Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev (2003) 1.71
Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr Pharm Des (2012) 1.71
Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci (2012) 1.69
Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder. Biol Psychiatry (2004) 1.66
Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res (2006) 1.62
Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry (2008) 1.59
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry (2004) 1.58
Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry (2006) 1.55
Attention and executive systems abnormalities in adults with childhood ADHD: A DT-MRI study of connections. Cereb Cortex (2007) 1.51
Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch Gen Psychiatry (2002) 1.49
Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Child Psychol Psychiatry (2005) 1.47
Genetic influences on cortical regionalization in the human brain. Neuron (2011) 1.46
MRI-based surface-assisted parcellation of human cerebellar cortex: an anatomically specified method with estimate of reliability. Neuroimage (2005) 1.44
Cortical thickness is influenced by regionally specific genetic factors. Biol Psychiatry (2009) 1.44
A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophr Res (2011) 1.44
Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability. Biol Psychiatry (2006) 1.44
The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res (2010) 1.43
Decreased absolute amygdala volume in cocaine addicts. Neuron (2004) 1.41
Fronto-temporal disconnectivity in schizotypal personality disorder: a diffusion tensor imaging study. Biol Psychiatry (2005) 1.41
Attention-deficit/hyperactivity disorder endophenotypes. Biol Psychiatry (2005) 1.40
Towards conceptualizing a neural systems-based anatomy of attention-deficit/hyperactivity disorder. Dev Neurosci (2009) 1.39
Medial prefrontal cortical activation during working memory differentiates schizophrenia and bipolar psychotic patients: a pilot FMRI study. Schizophr Res (2011) 1.38
Reduction of caudate nucleus volumes in neuroleptic-naïve female subjects with schizotypal personality disorder. Biol Psychiatry (2006) 1.36
Functional neuroanatomy of working memory in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.35
Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res (2012) 1.32
Emotion processing in persons at risk for schizophrenia. Schizophr Bull (2008) 1.31
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse? Neuron (2008) 1.27
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives. Schizophr Bull (2008) 1.24
Sex differences in prefrontal cortical brain activity during fMRI of auditory verbal working memory. Neuropsychology (2005) 1.23
Real-world cognitive--and metacognitive--dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff". Schizophr Bull (2006) 1.23
Sex differences in the functional neuroanatomy of working memory in adults with ADHD. Am J Psychiatry (2009) 1.21
The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophr Res (2009) 1.21
The neuropsychological basis of insight in first-episode schizophrenia: a pilot metacognitive study. Schizophr Res (2004) 1.21
Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review. Cogn Neuropsychiatry (2012) 1.19
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry (2008) 1.19
Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry (2008) 1.19
Extensive white matter abnormalities in patients with first-episode schizophrenia: a Diffusion Tensor Iimaging (DTI) study. Schizophr Res (2013) 1.19
Adjustment for whole brain and cranial size in volumetric brain studies: a review of common adjustment factors and statistical methods. Harv Rev Psychiatry (2006) 1.18
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res (2011) 1.17
Safety and proof of principle study of cerebellar vermal theta burst stimulation in refractory schizophrenia. Schizophr Res (2010) 1.17
Impaired intellect and memory: a missing link between genetic risk and schizophrenia? Arch Gen Psychiatry (2010) 1.15
The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophr Res (2010) 1.15
Diagnostic and sex effects on limbic volumes in early-onset bipolar disorder and schizophrenia. Schizophr Bull (2007) 1.15
Heterogeneity of schizophrenia: a study of individual neuropsychological profiles. Schizophr Res (2004) 1.13
Genetic and environmental contributions to regional cortical surface area in humans: a magnetic resonance imaging twin study. Cereb Cortex (2011) 1.13
A comparison of heritability maps of cortical surface area and thickness and the influence of adjustment for whole brain measures: a magnetic resonance imaging twin study. Twin Res Hum Genet (2012) 1.13
Whither the attenuated psychosis syndrome? Schizophr Bull (2012) 1.12
Human cerebral cortex: a system for the integration of volume- and surface-based representations. Neuroimage (2006) 1.12
Neuropsychological functioning in youth with bipolar disorder. Biol Psychiatry (2005) 1.11
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophr Res (2010) 1.11
Psychopathology, personality traits and social development of young first-degree relatives of patients with schizophrenia. Br J Psychiatry (2006) 1.11
Functional magnetic resonance imaging during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: a pilot study. Biol Psychiatry (2004) 1.09
Salivary cortisol and prefrontal cortical thickness in middle-aged men: A twin study. Neuroimage (2010) 1.09
Paternal age as a risk factor for schizophrenia: how important is it? Schizophr Res (2009) 1.09
Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2008) 1.07
Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age. J Alzheimers Dis (2011) 1.05
An fMRI study of working memory in persons with bipolar disorder or at genetic risk for bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 1.05
Neural substrates of impaired sensorimotor timing in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2010) 1.05
Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. Biol Psychiatry (2005) 1.05
Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychol Assess (2011) 1.05
Multivariate genomewide linkage scan of neurocognitive traits and ADHD symptoms: suggestive linkage to 3q13. Am J Med Genet B Neuropsychiatr Genet (2008) 1.03
A twin study of the neuropsychological consequences of stimulant abuse. Arch Gen Psychiatry (2003) 1.03
Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: further evidence. Environ Health Perspect (2008) 1.02
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. J Nerv Ment Dis (2015) 1.02
Premorbid cognitive deficits in young relatives of schizophrenia patients. Front Hum Neurosci (2010) 1.01